PPT-Polypharmacy: minimizing impact in older patients

Angela S Stewart PharmD BCPS Clinical Associate Professor Associate Dean Yakima Extension Objectives Upon completion of this program the participant should be able to Identify patients at highest risk for adverse drug events and the effects of polypharmacy. After . 40 . Years . O. ld. : So You Want to be Parents Now?. Alice D. Domar, Ph.D. Domar Center for Mind/Body Health, Boston IVF. Harvard Medical School . Main . F. ocus Points During Initial Patient Visit. Debra Bynum, MD. Associate Professor of Medicine. Division of Geriatric Medicine. University of North Carolina. March 2010. True or False?. 1. A healthy 90 year old woman is likely to live . to be 95…. Managing . multi-morbidity and multiple medications in geriatrics. Marilyn N. Bulloch, . PharmD. , BCPS. Assistant Clinical Professor. Harrison School of Pharmacy. Auburn University. The Hobson’s Choice in Geriatric Pharmacotherapy. HIV Infection. Howard Libman, MD. Professor of Medicine, Harvard Medical School. Director, HIV Program, Healthcare Associates. Beth Israel Deaconess Medical Center. Boston, . Massachusetts. Learning Objectives. HIV Infection. Howard Libman, MD. Professor of Medicine, Harvard Medical School. Director, HIV Program, Healthcare Associates. Beth Israel Deaconess Medical Center. Boston, . Massachusetts. Learning Objectives. Advanced Cancer. Supriya Mohile, MD, MS. Philip and Marilyn . Wehrheim. Professor. Co-Director, Cancer Prevention and Control Program, Wilmot Cancer Institute. Director, Geriatric Oncology Research Program . May 25, 2013. Mala Joneja, MD MEd FRCPC . Identify factors that contribute to risk in the medical treatment of Rheumatic Diseases in the elderly population. Identify risks associated with specific pharmacological interventions in the elderly. Addressing hearing-based communication barriers in the Emergency Department. REFERENCES. 1. Lin FR, Thorpe R, Gordon-. Salant. S, . Ferrucci. L. Hearing loss prevalence and risk factors among older adults in the United States. . Alfred Fisher MD PhD. Associate Professor and Chief. Division of Geriatrics, Gerontology, and Palliative Medicine. Department of Internal Medicine. University of Nebraska Medical Center. Al. ё. na A. Balasanova, M.D., FAPA. in . the Management of . HIV: . A Case-Based Discussion. Charles . W. Flexner. , MD. Professor . of Medicine, Pharmacology and Molecular Sciences, and International . Health. The Johns Hopkins University . related. . problems. in . older. . patients. Belgian. . Interuniversity. Course . Geriatrics. 20/05/2022. Annemie Somers. PharmD. , PhD. Ghent. University & . Ghent. University . Hospital. Polypharmacy. Alfred Fisher MD PhD. Professor and Chief. Division of Geriatrics, Gerontology, and Palliative Medicine. Department of Internal Medicine. University of Nebraska Medical Center. Al. ё. na A. Balasanova, M.D., FAPA. II. Polypharmacy issues. Medications who have limited or no evidence (docusate, ABD gel, low-dose antipsychotics at EOL, many supplements, Alzheimer’s drugs in patients with advanced dementia). Medications with little or no benefit because of time frame (calcium, iron, . Name, Title. Affiliation. Date. Disclaimer: Slide content developed by the Centers for Disease Control and Prevention. How to Use These Slides. Purpose: . Encourage uptake of a STEADI-based fall prevention program.